je.st
news
Merck Announces Sale of Consumer Care Business to Bayer AG for $14.2 Billion
2014-05-06 12:00:00| Merck.com - Financial News
Dateline City: BOSTON Enters into Worldwide Collaboration with Bayer to Market and Develop Novel Therapies for Cardiovascular Disease Collaboration Includes a $1 Billion Up-front Payment by Merck to Bayer BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms of the agreement, Bayer AG will acquire Mercks existing OTC business, including the global trademark and prescription rights for Claritin and Afrin. Language: English Contact: MerckMedia:Steve Cragle, 908-423-3461Pam Eisele, 267-305-3558orInvestors:Joe Romanelli, 908-423-5185Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: business
care
sale
consumer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||